4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-003081
Chief Financial Officer sold 20,000 shares at $29.87 ($597,400)
- Chief Financial Officer acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Cohen Chad M · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-01-08 | Exercise or conversion : show line 1 in the form | +20,000 | $4.07 | $81,400 | 21,000 | D |
| 2020-01-08 | Sale : show line 2 in the form | −20,000 | $29.87 | $597,400 | 1,000 | D |
| Open-market sales · 20,000 sh · avg $29.87 · $597,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-01-08 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −20,000 | 80,000 | D |
Loading xslF345X03/doc4.xml…